Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by ICU Medical, Inc. on May 13, 2026. The filing details the results of stockholder votes and the subsequent amendments to the Company's governance documents, which became effective upon filing with the Delaware Secretary of State on May 15, 2026.
Key Financial Metrics
This filing is a current report regarding corporate governance and stockholder actions. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Governance Amendments
Stockholders approved significant amendments to the Company's Amended and Restated Certificate of Incorporation and Bylaws:
- Majority Voting Amendment: Eliminated supermajority voting requirements, replacing them with simple majority voting provisions.
- Special Meeting Amendment: Granted stockholders owning at least 25% of the combined voting power the right to call a special meeting of stockholders.
- Procedural Requirements: New Bylaws established specific procedural and informational requirements for requesting special meetings, including record date determinations and restrictions on duplicative business items.
Voting Results and Management Commentary
The following proposals were voted on at the Annual Meeting:
- Proposal 1 (Election of Directors): All seven nominees (Vivek Jain, David C. Greenberg, Elisha W. Finney, David F. Hoffmeister, Donald M. Abbey, Laurie Hernandez, Kolleen T. Kennedy) were elected with overwhelming support (over 21.8 million votes for each).
- Proposal 2 (Auditor Ratification): Ratified the appointment of Deloitte & Touche LLP (23.86 million votes for).
- Proposal 3 (Executive Compensation): Approved advisory compensation (21.21 million votes for).
- Proposal 4 (Simple Majority Voting): Approved (22.12 million votes for).
- Proposal 5 (25% Special Meeting Right): Approved (20.74 million votes for).
- Proposal 6 (Adjournment): Approved the right to adjourn to solicit additional proxies if necessary (21.09 million votes for).
- Proposal 7 (10% Special Meeting Right): A stockholder proposal to establish a 10% threshold for calling special meetings was rejected (9.01 million votes for vs. 13.12 million votes against).
Investor Verification Checklist
- Verify the effective date of the Charter Amendments (May 15, 2026) and the filing of the Amended and Restated Certificate of Incorporation with the State of Delaware.
- Review the full text of the Amended and Restated Bylaws (Exhibit 3.2) to understand the specific procedural hurdles for the new 25% special meeting right.
- Confirm the rejection of the 10% special meeting right proposal, noting the significant vote against it.
- Check the Definitive Proxy Statement on Schedule 14A filed on April 2, 2026, for detailed background on the governance changes.